Top Stories
-
A new study has found that up to 20% of aggressive brain cancers are fueled by overactive mitochondria and new drugs in development may be able to starve the cancers.
Topic
-
Seizures are usually considered a side effect of brain cancer, but a new Columbia University study of mice suggests they may also fuel the further growth of brain tumors.
Topic
-
At Columbia, patients with brain cancer will be able to participate in a new type of clinical trial that promises to speed up the development of better drugs for glioblastoma.
Topic
-
Fewer than 1 in 10 patients with glioblastoma—the most common type of brain cancer—respond to immunotherapy; a new study reveals how to detect patients who may respond.
Topic
Latest News
- March 30, 2018
Though far from the most common form of cancer, brain cancers are uniquely difficult to treat. Columbia scientists are researching multiple new ways to attack the tumors.
Topic
- January 3, 2018
The fusion of two adjacent genes can cause cancer by kicking mitochondria into overdrive and increasing the amount of fuel available for rampant cell growth.
Topic
- February 9, 2015
The drug Gleevec is well known not only for its effectiveness against leukemia. A similar drug might be able to tame some brain cancers, new research from Columbia University Medical Center has shown.
Topic
- July 30, 2014
Columbia experts worked together to offer an innovative option to a pregnant woman needing radiation therapy for a fast-growing brain tumor.
Topic
- August 29, 2013
With an HHMI fellowship, Columbia medical student Eli Sayegh is taking a year off from school to research a new theory about brain cancer.
Topic
- August 5, 2013
A study has found 18 new genes that drive an aggressive form of brain cancer, doubling the number of known driver genes of glioblastoma.
Topic
- March 5, 2013
Scientists discovered how common genetic mutations in Parkinson’s disease damage brain cells
Topic
- February 20, 2013
Omega-3 lipid emulsions protect brain after stroke in mouse study
Topic
- February 19, 2013
It's not just amyloid; white matter hyperintensities may be a second necessary factor for the development of Alzheimer’s.
Topic
- February 19, 2013
Dr. Carla Shatz Honored With the Mortimer D. Sackler, M.D. Prize for Distinguished Achievement in Developmental Psychobiology
Topic
